Redmile Group, LLC Buys Bristol-Myers Squibb Company, Clovis Oncology Inc, Medtronic PLC, Sells WellCare Health Plans Inc, bluebird bio Inc, Anthem Inc

• New Purchases: BMY, MDT, TEVA, ATRC, AXNX, GBT, KRYS, GWPH, IRTC, SBBP,
• Added Positions: CLVS, EPZM, JAZZ, ALLK, WMGI, ARRY, ATRA, DCPH, XNCR, BOLD, GRTS, SAGE, MYOK, OVID,
• Reduced Positions: ANTM, ANAB, ICUI, RGNX, LHCG, CI, HSKA, IMGN, QURE, TDOC, EHTH, PEN, LIVN, UNH, NITE, ODT, WVE, TNDM, JNCE, ARGX, GLYC, CVS, PRAH, RGEN, CBAY, VKTX, ESTA, ELGX, EIDX, VCEL,
• Sold Out: WCG, BLUE, CNC, NUVA, CTLT, PRQR, ZTS, SYNH, A, ELAN, SGRY, IIN, STIM, RMED, SENS, HRTX, AMED, IHF,

For the details of Redmile Group, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/redmile+group%2C+llc/current-portfolio/portfolio

1. Array BioPharma Inc (ARRY) - 16,459,128 shares, 9.78% of the total portfolio. Shares added by 3.47%
2. Atara Biotherapeutics Inc (ATRA) - 4,414,617 shares, 6.39% of the total portfolio. Shares added by 4.64%
3. Fate Therapeutics Inc (FATE) - 10,576,363 shares, 5.66% of the total portfolio.
4. Xencor Inc (XNCR) - 3,084,703 shares, 4.65% of the total portfolio. Shares added by 1.80%
5. WAVE Life Sciences Ltd (WVE) - 2,237,607 shares, 3.92% of the total portfolio. Shares reduced by 1.57%

Redmile Group, LLC initiated holding in Bristol-Myers Squibb Company. The purchase prices were between $48.76 and $63.23, with an estimated average price of $53.49. The stock is now traded at around $50.13. The impact to a portfolio due to this purchase was 1.85%. The holding were 854,700 shares as of .

Redmile Group, LLC initiated holding in Medtronic PLC. The purchase prices were between $85.8 and $99.02, with an estimated average price of $93.28. The stock is now traded at around $92.61. The impact to a portfolio due to this purchase was 1.59%. The holding were 419,900 shares as of .

Redmile Group, LLC initiated holding in Teva Pharmaceutical Industries Ltd. The purchase prices were between $14.59 and $23.84, with an estimated average price of $20.42. The stock is now traded at around $17.25. The impact to a portfolio due to this purchase was 1.18%. The holding were 1,828,900 shares as of .

Redmile Group, LLC initiated holding in AtriCure Inc. The purchase prices were between $26.66 and $33.69, with an estimated average price of $31.06. The stock is now traded at around $32.78. The impact to a portfolio due to this purchase was 0.38%. The holding were 300,000 shares as of .

Redmile Group, LLC initiated holding in Axonics Modulation Technologies Inc. The purchase prices were between $13.2 and $16.43, with an estimated average price of $14.87. The stock is now traded at around $22.50. The impact to a portfolio due to this purchase was 0.38%. The holding were 600,000 shares as of .

Redmile Group, LLC initiated holding in Global Blood Therapeutics Inc. The purchase prices were between $31.54 and $46.67, with an estimated average price of $37.55. The stock is now traded at around $50.00. The impact to a portfolio due to this purchase was 0.29%. The holding were 167,600 shares as of .

Redmile Group, LLC added to a holding in Clovis Oncology Inc by 128.34%. The purchase prices were between $11.63 and $32.67, with an estimated average price of $20.2. The stock is now traded at around $24.18. The impact to a portfolio due to this purchase was 1.71%. The holding were 4,060,529 shares as of .

Redmile Group, LLC added to a holding in Epizyme Inc by 195.23%. The purchase prices were between $5.22 and $9.71, with an estimated average price of $7.53. The stock is now traded at around $11.72. The impact to a portfolio due to this purchase was 1.12%. The holding were 6,637,278 shares as of .

Redmile Group, LLC added to a holding in Jazz Pharmaceuticals PLC by 8496.23%. The purchase prices were between $115.94 and $166.74, with an estimated average price of $147.58. The stock is now traded at around $125.21. The impact to a portfolio due to this purchase was 0.7%. The holding were 136,680 shares as of .

Redmile Group, LLC added to a holding in Sage Therapeutics Inc by 35.94%. The purchase prices were between $81.94 and $139.71, with an estimated average price of $113.76. The stock is now traded at around $146.18. The impact to a portfolio due to this purchase was less than 0.01%. The holding were 2,950 shares as of .

Redmile Group, LLC sold out a holding in WellCare Health Plans Inc. The sale prices were between $221.21 and $319.24, with an estimated average price of $265.73.

Redmile Group, LLC sold out a holding in bluebird bio Inc. The sale prices were between $91.25 and $144, with an estimated average price of $117.56.

Redmile Group, LLC sold out a holding in Centene Corp. The sale prices were between $54.55 and $73.42, with an estimated average price of $66.73.

Redmile Group, LLC sold out a holding in NuVasive Inc. The sale prices were between $47.64 and $69.86, with an estimated average price of $59.82.

Redmile Group, LLC sold out a holding in Catalent Inc. The sale prices were between $29.95 and $46.34, with an estimated average price of $38.32.

Redmile Group, LLC sold out a holding in ProQR Therapeutics NV. The sale prices were between $15.25 and $22.4, with an estimated average price of $18.35.

Redmile Group, LLC reduced to a holding in Anthem Inc by 50.64%. The sale prices were between $249 and $296.25, with an estimated average price of $274.89. The stock is now traded at around $311.30. The impact to a portfolio due to this sale was -1.01%. Redmile Group, LLC still held 115,500 shares as of .

Redmile Group, LLC reduced to a holding in AnaptysBio Inc by 42.24%. The sale prices were between $55.4 and $96.68, with an estimated average price of $73.87. The stock is now traded at around $64.94. The impact to a portfolio due to this sale was -0.83%. Redmile Group, LLC still held 364,050 shares as of .

Redmile Group, LLC reduced to a holding in ICU Medical Inc by 49.82%. The sale prices were between $213.13 and $278.29, with an estimated average price of $245.69. The stock is now traded at around $252.99. The impact to a portfolio due to this sale was -0.8%. Redmile Group, LLC still held 91,321 shares as of .